A study to know the effects of magnesiun sulphate and fentanyl in spinal anesthesia.
Not yet recruiting
- Conditions
- Disease of digestive system, unspecified,
- Registration Number
- CTRI/2022/03/041477
- Lead Sponsor
- Mayo institute of medical sciences
- Brief Summary
**There have been several studies conducted where adjuvants added to local anesthetic agent for prolongation of analgesic effect.**
**From this study we would like to find out the efficacy of blockade,duration of analgesia,requirement of analgesic dose after addition of magnesium sulphate and fentanyl to bupivacaine in subarachnoid block.**
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Consent for participation in the study Both sex Age 18 to 55 years ASA grade 1 and 11 Infraumbilical surgeries.
Exclusion Criteria
Refusal for participation in the study ASA Grade above III History of any drug allergies Opioid addicts Anatomical spinal deformities/malformations Any chronic comorbidity Any acute URTI or fever.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Block characteristics 12-18 weeks 2. Hemodynamic stability in intra and post-operative phase 12-18 weeks 3. Post-operative requirement of rescue analgesia and its dose 12-18 weeks
- Secondary Outcome Measures
Name Time Method Onset and regression of sensory and motor blocks 14-20 weeks
Trial Locations
- Locations (1)
Mayo institute of medical sciences
🇮🇳Barabanki, UTTAR PRADESH, India
Mayo institute of medical sciences🇮🇳Barabanki, UTTAR PRADESH, IndiaGagandeep kaurPrincipal investigator9896043154gagandeeplakhyan28@gmail.com